Abeona Therapeutics (ABEO) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free ABEO Stock Alerts $4.21 +0.15 (+3.69%) (As of 05/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 7:34 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 30 at 8:28 AM | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Coverage Initiated by Analysts at Stifel NicolausStifel Nicolaus began coverage on shares of Abeona Therapeutics in a research report on Thursday. They set a "buy" rating and a $21.00 target price for the company.May 30 at 5:41 AM | marketbeat.comQ2 2024 EPS Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO) Lifted by AnalystAbeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Zacks Small Cap raised their Q2 2024 earnings per share estimates for Abeona Therapeutics in a research report issued on Tuesday, May 28th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will post earnings ofMay 28 at 3:06 PM | msn.comABEO: BLA Resubmission in 2H24May 28 at 7:30 AM | globenewswire.comAbeona Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 27 at 5:55 PM | marketbeat.comAIGH Capital Management LLC Has $3.95 Million Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)AIGH Capital Management LLC decreased its holdings in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 30.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 787,769 shares of the biopharmaceutical company's stockMay 23, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 22, 2024 | uk.investing.comAbeona Therapeutics director buys $51,798 in company stockMay 21, 2024 | americanbankingnews.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Leila Alland Buys 11,000 Shares of StockMay 21, 2024 | insidertrades.comLeila Alland Acquires 11,000 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) StockMay 20, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Leila Alland Purchases 11,000 SharesAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) Director Leila Alland purchased 11,000 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was acquired at an average cost of $4.71 per share, with a total value of $51,810.00. Following the completion of the acquisition, the director now directly owns 82,857 shares of the company's stock, valued at $390,256.47. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.May 20, 2024 | americanbankingnews.comCantor Fitzgerald Equities Analysts Lift Earnings Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO)May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 16, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Cut to $21.00 by Analysts at Cantor FitzgeraldCantor Fitzgerald decreased their target price on shares of Abeona Therapeutics from $28.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday.May 16, 2024 | finance.yahoo.comQ1 2024 Abeona Therapeutics Inc Earnings CallMay 16, 2024 | finance.yahoo.comAbeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...May 15, 2024 | washingtonpost.comAbeona Therapeutics: Q1 Earnings SnapshotMay 15, 2024 | investorplace.comABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024May 15, 2024 | globenewswire.comAbeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate ProgressMay 7, 2024 | globenewswire.comAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOMay 3, 2024 | marketwatch.comAbeona Therapeutics Shares Rise After Underwritten Offering Gets PricedMay 3, 2024 | markets.businessinsider.comAbeona Prices Offering Of $75 Mln Common Stock, WarrantsMay 3, 2024 | finance.yahoo.comAbeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsMay 2, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsMay 1, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsApril 30, 2024 | insidertrades.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Buys $24,764.00 in StockApril 29, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of InvestorsApril 29, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Director Faith L. Charles Purchases 7,550 SharesAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) Director Faith L. Charles bought 7,550 shares of Abeona Therapeutics stock in a transaction on Friday, April 26th. The shares were acquired at an average price of $3.28 per share, for a total transaction of $24,764.00. Following the completion of the acquisition, the director now owns 78,323 shares of the company's stock, valued at approximately $256,899.44. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.April 27, 2024 | insidertrades.comInsider Buying: Abeona Therapeutics Inc (NASDAQ:ABEO) CFO Acquires 5,608 Shares of StockApril 27, 2024 | insidertrades.comAbeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Acquires 8,600 SharesApril 26, 2024 | marketbeat.comFY2024 EPS Estimates for Abeona Therapeutics Inc Cut by Analyst (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Research analysts at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Abeona Therapeutics in a report released on Wednesday, April 24th. Cantor Fitzgerald analyst K. Kluska now expects that the biopharmaceutical companyApril 25, 2024 | finance.yahoo.comABEO: Receives CRL Based on Need for More CMC Information…April 23, 2024 | seekingalpha.comAbeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not LostApril 23, 2024 | finanznachrichten.deAbeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-celApril 23, 2024 | msn.comFDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares SinkApril 23, 2024 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating for Abeona Therapeutics (NASDAQ:ABEO)Cantor Fitzgerald reiterated an "overweight" rating and set a $36.00 target price on shares of Abeona Therapeutics in a research report on Tuesday.April 23, 2024 | investorplace.comWhy Is Abeona Therapeutics (ABEO) Stock Down 45% Today?April 22, 2024 | marketwatch.comAbeona Therapeutics Shares Down 53% After FDA Complete Response LetterApril 22, 2024 | reuters.comUS FDA declines to approve Abeona's skin disorder treatmentApril 22, 2024 | globenewswire.comAbeona Therapeutics Provides Regulatory Update on Pz-celApril 22, 2024 | marketbeat.comTrading was temporarily halted for "ABEO" at 04:04 PM with a stated reason of "News pending."April 15, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to "Hold"StockNews.com upgraded shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a report on Monday.April 1, 2024 | globenewswire.comAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 27, 2024 | finance.yahoo.comHere's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn SituationMarch 22, 2024 | marketbeat.comAnalysts Issue Forecasts for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for Abeona Therapeutics in a note issued to investors on Tuesday, March 19th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biopharmaceutical company will earnMarch 19, 2024 | investorplace.comABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023March 19, 2024 | finance.yahoo.comQ4 2023 Abeona Therapeutics Inc Earnings CallMarch 19, 2024 | finance.yahoo.comAbeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial ResultsMarch 18, 2024 | msn.comInventiva Phase 2 study for MASH drug meets primary endpoint Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career… Click For My #1 FREE Crypto for 2024 ABEO Media Mentions By Week ABEO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.880.80▲Average Medical News Sentiment ABEO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼102▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CervoMed News Coya Therapeutics News Adagene News Cellectar Biosciences News Immunic News Allakos News Rezolute News FibroGen News Nuvectis Pharma News PDS Biotechnology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaThe only financial event in 2024 that matters Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
